Paediatric and congenital heart disease in South America: An overview

Heart

Volumn 95, Issue 17, 2009, Pages 1385-1392

  Pedra, C A C ^a   Haddad, J ^b   Pedra, S F ^a   Peirone, A ^c   Pilla, C B ^d   Marin Neto, J A ^b  

^a INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Hospital de Niños de la Santíssima Trinidad ^*  (Argentina)

^d HOSPITAL SÃO FRANCISCO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

AORTA COARCTATION; AORTA STENOSIS; ARTERIAL TRUNK; AUTOPSY; BLALOCK TAUSSIG SHUNT; CONGENITAL HEART DISEASE; DEVICE THERAPY; ECHOCARDIOGRAPHY; FALLOT TETRALOGY; FONTAN PROCEDURE; GREAT VESSELS TRANSPOSITION; HEALTH CARE FACILITY; HEALTH INSURANCE; HEART ATRIUM SEPTUM DEFECT; HEART CATHETERIZATION; HEART TRANSPLANTATION; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; INCIDENCE; LUNG ARTERY BANDING; OUTCOME ASSESSMENT; PATENT DUCTUS ARTERIOSUS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULMONARY VALVE ATRESIA; PULMONARY VALVE STENOSIS; REVIEW; RISK FACTOR; SOUTH AMERICA; STERNOTOMY; SURGICAL MORTALITY; TRANSLUMINAL VALVULOPLASTY;

EID: 69249088971     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2008.152017     Document Type: Review

References (123)

1. Hoffman JIE. Incidence, mortality and natural history. In: Anderson RH, Baker EJ, MaCartney FJ, et al., eds Paediatric cardiology. 2nd ed. London: Churchill Livingstone, 2002:111-39.
2. Baltaxe E, Zarante I. Prevalence of congenital heart disease in 44,985 newborns in Colombia. Arch Cardiol Mex 2006;76:263-8.
3. Amorim LF, Pires CA, Lana AM, et al. Presentation of congenital heart disease diagnosed at birth: analysis of 29,770 newborn infants. J Pediatr 2008;84:83-90.
4. Guitti JC. Epidemiological characteristics of congenital heart diseases in Londrina, Paraná, South Brazil. Arq Bras Cardiol 2000;74:395-404.
5. Hagemann LL, Zielinsky P. Population screening of fetal cardiac abnormalities through prenatal echocardiography in low-risk pregnancies in the municipality of Porto Alegre. Arq Bras Cardiol 2004;82:313-26.
6. Miyague NI, Cardoso SM, Meyer F, et al. Epidemiological study of congenital heart defects in children and adolescents. Analysis of 4,538 cases. Arq Bras Cardiol 2003;80:269-78.
7. Todd J, Armon C, Griggs A, et al. Increased rates of morbidity, mortality, and charges for hospitalized children with public or no health insurance as compared with children with private insurance in Colorado and the United States. Pediatrics 2006;118:577-85.
8. Pedra CA, Pontes SC Jr, Pedra SR, et al. Percutaneous closure of postoperative and post-traumatic ventricular septal defects. J Invasive Cardiol 2007;19:491-5.
9. Pedra CA, Pedra SR, Esteves CA, et al. Percutaneous closure of perimembranous ventricular septal defects with the Amplatzer device: technical and morphological considerations. Catheter Cardiovasc Interv 2004;61:403-10.
10. Queiróz FJ, Rossi Filho RI, Ramos S, et al. Percutaneous occlusion of interventricular septal defects. Initial experiment. Arq Bras Cardiol 2005;85:174-9.
11. Sideris EB, Haddad J, Rao PS. The role of the 'Sideris' devices in the occlusion of ventricular septal defects. Curr Interv Cardiol Rep 2001;3:349-53.
12. Sideris EB, Walsh KP, Haddad JL, et al. Occlusion of congenital ventricular septal defects by the buttoned device. "Buttoned device" Clinical Trials International Register. Heart 1997;77:276-9.
13. Becker P, Frangini P, Heusser F, et al. New surgical approach to device closure of multiple apical ventricular septal defects. Rev Esp Cardiol 2004;57:1238-40.
14. Braga SL, Sousa AG, Pedra CA, et al. Clinical efficacy and safety of the percutaneous treatment of secundum atrial septal defect with the Amplatzer occluder. Arq Bras Cardiol 2004;83:7-13.
15. Pedra CA, Pedra SR, Esteves CA, et al. Transcatheter closure of secundum atrial septal defects with complex anatomy. J Invasive Cardiol 2004;16:117-22.
16. Pedra CA, Pedra SF, Esteves CA, et al. Initial experience in Brazil with the Helex septal occluder for percutaneous occlusion of atrial septal defects. Arq Bras Cardiol 2003;81:435-52.
17. Pedra CA, Fontes-Pedra SR, Esteves CA, et al. Multiple atrial septal defects and patent ductus arteriosus: successful outcome using two Amplatzer septal occluders and Gianturco coils. Catheter Cardiovasc Diagn 1998;45:257-9.
18. Faella HJ, Sciegata AM, Alonso JL, et al. ASD closure with the Amplatzer device. J Interv Cardiol 2003;16:393-7.
19. Rossi RI, Cardoso Cde O, Machado PR, et al. Transcatheter closure of atrial septal defect with Amplatzer device in children aged less than 10 years old: immediate and late follow-up. Catheter Cardiovasc Interv 2008;71:231-6.
20. Cardoso CO, Rossi Filho RI, Machado PR, et al. Effectiveness of the Amplatzer device for transcatheter closure of an ostium secundum atrial septal defect. Arq Bras Cardiol 2007;88:384-9.
21. Haddad J, Secches A, Finzi L, et al. Atrial septal defect percutaneous transvenous occlusion with the buttoned device. Arq Bras Cardiol 1996;67:17-22.
22. Rao PS, Berger F, Rey C, et al. Results of transvenous occlusion of secundum atrial septal defects with the fourth generation buttoned device: comparison with first, second and third generation devices. International Buttoned Device Trial Group. J Am Coll Cardiol 2000;36:583-92.
23. Barbero-Marcial M, Tanamati C, Jatene MB, et al. Transxiphoid approach without median sternotomy for the repair of atrial septal defects. Ann Thorac Surg 1998;65:771-4.
24. Pedra CA, Pedra SR, Esteves CA, et al. Overall experience with percutaneous occlusion of patent ductus arteriosus. Arq Bras Cardiol 1998;71:769-80.
25. Pedra CA, Esteves CA, Pedra SR, et al. Indications, technique, results and clinical impact of reocclusion procedures for residual shunts after transcatheter closure of the patent ductus arteriosus. Arch Inst Cardiol Mex 1999;69:320-9.
26. Simões LC, Pedra CA, Esteves CA, et al. Percutaneous closure of ductus arteriosus with the amplatzer prosthesis. The Brazilian experience. Arq Bras Cardiol 2001;77:520-31.
27. Santiago J, Acuña M, Arispe E, et al. Right patent ductus arteriosus with an ipsilateral aortic arch: percutaneous closure with Amplatzer devices. Rev Esp Cardiol 2007;60:319-22.
28. Faella H, Hijazi ZM. Closure of the patent ductus arteriosus with the Amplatzer PDA device: immediate results of the international clinical trial. Catheter Cardiovasc Interv 2000;51:50-4.
29. Rao PS, Kim SH, Choi JY, et al. Follow-up results of transvenous occlusion of patent ductus arteriosus with the buttoned device. J Am Coll Cardiol 1999;33:820-6.
30. Pedra CA, Sanches SA, Fontes VF. Percutaneous occlusion of the patent ductus arteriosus with the Amplatzer device for atrial septal defects. J Invasive Cardiol 2003;15:413-7.
31. Pedra CAC, Esteves CA, Braga SLN, et al. Percutaneous closure of the small patent ductus arteriosus with Gianturco coils. Impact of the optimal patient and coil selection and the no tolerance policy for significant immediate leaks on the outcomes. Revista Brasileira de Cardiologia Invasiva 2008;16:86-90.
32. Pedra CA, Pedra SR, Esteves CA, et al. Simultaneous treatment of pulmonary valve stenosis and patent ductus arterious by interventional catheterization. Arq Bras Cardiol 1997;68:357-62.
33. Pedra CA, Pedra SR, Braga SL, et al. Short- and midterm follow-up results of valvuloplasty with balloon catheter for congenital aortic stenosis. Arq Bras Cardiol 2003;81:120-8, 111-9.
34. Fontes VF, Sousa JE, Esteves CA, et al. Pulmonary valvoplasty-experience of 100 cases. Int J Cardiol 1988;21:335-42.
35. Cazzaniga M, Faella H, Laneri D, et al. Percutaneous balloon valvotomy in neonatal obstructive cardiopathy. I: Critical pulmonary valvular stenosis. An Esp Pediatr 1993;38:295-9.
36. Cazzaniga M, Vagnola O, Alday L, et al. Balloon pulmonary valvuloplasty in infants: a quantitative analysis of pulmonary valve-anulus-trunk structure. J Am Coll Cardiol 1992;20:345-9.
37. Hatem DM, Castro I, Haertel JC, et al. Short- and long- term results of percutaneous balloon valvuloplasty in pulmonary valve stenosis. Arq Bras Cardiol 2004;82:221-7.
38. Fontes VF, Esteves CA, Sousa JE, et al. Regression of infundibular hypertrophy after pulmonary valvuloplasty for pulmonic stenosis. Am J Cardiol 1988;62:977-9.
39. Fontes VF, Esteves CA, Braga SL, et al. Pulmonary atresia with intact ventricular septum. Valvar perforation by radiofrequency. Arq Bras Cardiol 1995;64:231-3.
40. Pedra CA, de Sousa LN, Pedra SR, et al. New percutaneous techniques for perforating the pulmonary valve in pulmonary atresia with intact ventricular septum. Arq Bras Cardiol 2001;77:471-86.
41. Pedra CA, Filho RM, Arrieta RS, et al. Recanalization of a discrete atretic right pulmonary artery segment with a new radiofrequency system. Catheter Cardiovasc Interv 2003;60:82-7.
42. Pedra CA, Neves JR, Pedra SR, et al. New transcatheter techniques for creation or enlargement of atrial septal defects in infants with complex congenital heart disease. Catheter Cardiovasc Interv 2007;70:731-9.
43. Pedra CA, Arrieta SR, Esteves CA, et al. Double balloon pulmonary valvuloplasty: multi-track system versus conventional technique. Catheter Cardiovasc Interv 2006;68:193-8.
44. Cazzaniga M, Faella H, Gamboa R, et al. Percutaneous balloon valvotomy in neonatal obstructive cardiopathy. II. Critical aortic valve stenosis. An Esp Pediatr 1993;38:407-12.
45. Lopes LM, Cha SC, Kajita LJ, et al. Balloon dilatation of the aortic valve in the fetus. A case report. Fetal Diagn Ther 1996;11:296-300.
46. Fontes VF, Esteves CA, Braga SL, et al. It is valid to dilate native aortic coarctation with a balloon catheter. Int J Cardiol 1990;27:311-6.
47. Pedra CA, Fontes VF, Esteves CA, et al. Stenting vs. balloon angioplasty for discrete unoperated coarctation of the aorta in adolescents and adults. Catheter Cardiovasc Interv 2005;64:495- 506.
48. Pedra CA, Fontes VF, Esteves CA, et al. Use of covered stents in the management of coarctation of the aorta. Pediatr Cardiol 2005;26:431-9.
49. Parodi JC, Ferreira LM, Faella H, et al. Use of covered stents and endograft as a rescue treatment in a patient with a complex form of recurrent aortic coarctation. J Vasc Surg 2007;45:1263-7.
50. Smith Maia MM, Cortês TM, Parga JR, et al. Evolutional aspects of children and adolescents with surgically corrected aortic coarctation: clinical, echocardiographic, and magnetic resonance image analysis of 113 patients. J Thorac Cardiovasc Surg 2004;127:712-20.
51. Croti UA, Braile DM, de Marchi CH, et al. Aortic coarctation: aortoplasty with interposition of the left subclavian artery (the Teles Mendonça technique). Rev Bras Cir Cardiovasc 2007;22:255-6
52. Jatene AD, Fontes VF, Paulista PP, et al. Successful anatomic correction of transposition of the great vessels. A preliminary report. Arq Bras Cardiol 1975;28:461-64.
53. Jatene AD, Fontes VF, Paulista PP, et al. Anatomic correction of transposition of the great vessels. J Thorac Cardiovasc Surg 1976;72:364-70.
54. Jatene AD, Fontes VF, Souza LC, et al. Anatomic correction of transposition of the great arteries. J Thorac Cardiovasc Surg 1982;83:20-6.
55. Kreutzer G, Neirotti R, Galíndez E, et al. Anatomic correction of transposition of the great arteries. J Thorac Cardiovasc Surg 1977;73:538-42.
56. Jatene FB, Bosisio IB, Jatene MB, et al. Late results (50 to 182 months) of the Jatene operation. Eur J Cardiothorac Surg 1992;6:575-7.
57. da Silva JP, Baumgratz JF, da Fonseca L. Pulmonary root translocation in transposition of great arteries repair. Ann Thorac Surg 2000;69:643-5.
58. Pedra SR, Pedra CA, Abizaid AA, et al. Intracoronary ultrasound assessment late after the arterial switch operation for transposition of the great arteries. J Am Coll Cardiol 2005;45:2061-8.
59. Vargas FJ, Kreutzer GO, Pedrini M, et al. Tetralogy of Fallot with subarterial ventricular septal defect. Diagnostic and surgical considerations. J Thorac Cardiovasc Surg 1986;92:908-12.
60. Schlichter AJ, Kreutzer C, Mayorquim RC, et al. Five- to fifteen-year follow-up of fresh autologous pericardial valved conduits. J Thorac Cardiovasc Surg 2000;119:869-79.
61. Atik FA, Atik E, da Cunha CR, et al. Long-term results of correction of tetralogy of Fallot in adulthood. Eur J Cardiothorac Surg 2004;25:250-5.
62. Barbero-Marcial M, Tanamati C, Atik E, et al. Intraventricular repair of double-outlet right ventricle with noncommitted ventricular septal defect: advantages of multiple patches. J Thorac Cardiovasc Surg 1999;118:1056-67.
63. Barbero-Marcial M, Baucia JA, Jatene A. Valved conduits of bovine pericardium for right ventricle to pulmonary artery connections. Semin Thorac Cardiovasc Surg 1995;7:148-53.
64. Barbero-Marcial M, Jatene AD. Surgical management of the anomalies of the pulmonary arteries in the tetralogy of Fallot with pulmonary atresia. Semin Thorac Cardiovasc Surg 1990;2:93-107.
65. Barbero-Marcial M, Atik E, Baucia JA, et al. Reconstruction of stenotic or nonconfluent pulmonary arteries simultaneously with a Blalock-Taussig shunt. J Thorac Cardiovasc Surg 1988;95:82-9.
66. Barbero-Marcial M, Rizzo A, Lopes AA, et al. Correction of pulmonary atresia with ventricular septal defect in the absence of the pulmonary trunk and the central pulmonary arteries (so-called truncus type IV). J Thorac Cardiovasc Surg 1987;94:911-4.
67. Barbero-Marcial M, Riso A, Atik E, et al. A technique for correction of truncus arteriosus types I and II without extracardiac conduits. J Thorac Cardiovasc Surg 1990;99:364-9.
68. Barbero-Marcial M, Tanamati C. Alternative nonvalved techniques for repair of truncus arteriosus: long-term results. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 1999;2:121-30.
69. Kreutzer GO. Truncus arteriosus repair: influence of techniques of right ventricular outflow tract reconstruction. J Thorac Cardiovasc Surg 1997;113:425.
70. Silva JP, Fonseca L, Baumgratz JF, et al. Hypoplastic left heart syndrome: the influence of surgical strategy on outcomes. Arq Bras Cardiol 2007;88:354-60.
71. da Silva JP, da Fonseca L, Baumgratz JF, et al. Hypoplastic left heart syndrome: the report of a surgical strategy and comparative results of Norwood x Norwood-Sano approach. Rev Bras Cir Cardiovasc 2007;22:160-8.
72. Pilla CB, Pedra CA, Nogueira AJ, et al. Hybrid management for hypoplastic left heart syndrome: an experience from Brazil. Pediatr Cardiol 2008;29:498-506.
73. Assad RS, Zamith MM, Silva MF, et al. A novel adjustable pulmonary artery banding system for hypoplastic left heart syndrome. Ann Thorac Surg 2007;84:2081-4.
74. Becker P, Frangini P, Urcelay G, et al. Immediate results of palliative surgery for different forms of univentricular heart using the Norwood procedure. Rev Med Chil 2004;132:556-63.
75. Kreutzer G, Galíndez E, Bono H, et al. An operation for the correction of tricuspid atresia. J Thorac Cardiovasc Surg 1973;66:613-21
76. Kreutzer GO, Vargas FJ, Schlichter AJ, et al. Atriopulmonary anastomosis. J Thorac Cardiovasc Surg 1982;83:427- 36.
77. Kreutzer GO, Allaria AE, Schlichter AJ, et al. A comparative long-term follow-up of the results of anterior and posterior approaches in bypassing the rudimentary right ventricle in patients with tricuspid atresia. Int J Cardiol 1988;19:167-79.
78. Kreutzer C, Schlichter A, Kreutzer G. Cavo atriopulmonary anastomosis via a nonprosthetic medial tunnel. J Card Surg 1997;12:37-40.
79. Kreutzer C, Mayorquim RC, Kreutzer GO, et al. Experience with one and a half ventricle repair. J Thorac Cardiovasc Surg 1999;117:662-8.
80. Kreutzer C, Schlichter AJ, Simon JL, et al. A new method for reliable fenestration in extracardiac conduit Fontan operations. Ann Thorac Surg 2003;75:1657-9.
81. Kreutzer GO. Thirty-two years after total right heart bypass. J Thorac Cardiovasc Surg 2007;134:1351-2.
82. Atik E, Ikari NM, Martins TC, et al. Fontan operation and the cavopulmonary technique: immediate and late results according to the presence of atrial fenestration. Arq Bras Cardiol 2002;78:162-6.
83. Mastalir ET, Kalil RA, Horowitz ES, et al. Late clinical outcomes of the Fontan operation in patients with tricuspid atresia. Arq Bras Cardiol 2002;79:56-60.
84. Becker P, Frangini P, Urcelay G, et al. Fontan procedure: early and mid-term results with total cavopulmonary anastomosis. Rev Med Chil 2002;130:1217-26.
85. Picarelli D, Montenegro JL, Antunez S, et al. Modified fenestration technique for the Kawashima operation in a young infant. J Thorac Cardiovasc Surg 2005;129:451-2.
86. Binotto MA, Higuchi Mde L, Aiello VD. Left ventricular remodeling in hearts with tricuspid atresia: morphologic observations and possible basis for ventricular dysfunction after surgery. J Thorac Cardiovasc Surg 2003;126:1026-32.
87. Binotto MA, Maeda NY, Lopes AA. Evidence of endothelial dysfunction in patients with functionally univentricular physiology before completion of the Fontan operation. Cardiol Young 2005;15:26-30.
88. Binotto MA, Maeda NY, Lopes AA. Altered endothelial function following the Fontan procedure. Cardiol Young 2008;18:70-4.
89. Lopes AA, Caramurú LH, Maeda NY. Endothelial dysfunction associated with chronic intravascular coagulation in secondary pulmonary hypertension. Clin Appl Thromb Hemost 2002;8:353-8.
90. Caramuru LH, Maeda NY, Bydlowski SP, et al. Age-dependent likelihood of in situ thrombosis in secondary pulmonary hypertension. Clin Appl Thromb Hemost 2004;10:217-23.
91. Maeda NY, Bydlowski SP, Lopes AA. Increased tyrosine phosphorylation of platelet proteins including pp125(FAK) suggests endogenous activation and aggregation in pulmonary hypertension. Clin Appl Thromb Hemost 2005;11:411-5.
92. de P S Soares R, Maeda NY, Bydlowski SP, et al. Markers of endothelial dysfunction and severity of hypoxaemia in the Eisenmenger syndrome. Cardiol Young 2005;15:504-13.
93. Caramuru LH, Lopes AA, Maeda NY, et al. Long-term behavior of endothelial and coagulation markers in Eisenmenger syndrome. Clin Appl Thromb Hemost 2006;12:175-83.
94. Aiello VD, Fukasawa S, da Silva MJ, et al. Systematic quantification of the arteries in lung biopsies of patients with congenital heart defects and its contribution to the therapeutic management. Arq Bras Cardiol 1997;68:3-8.
95. Egito ES, Aiello VD, Bosisio IB, et al. Vascular remodeling process in reversibility of pulmonary arterial hypertension secondary to congenital heart disease. Pathol Res Pract 2003;199:521-32.
96. Pinto RF, Higuchi Mde L, Aiello VD. Decreased numbers of T-lymphocytes and predominance of recently recruited macrophages in the walls of peripheral pulmonary arteries from 26 patients with pulmonary hypertension secondary to congenital cardiac shunts. Cardiovasc Pathol 2004;13:268-75.
97. Lopes AA, Maeda NY, Aiello VD, et al. Abnormal multimeric and oligomeric composition is associated with enhanced endothelial expression of von Willebrand factor in pulmonary hypertension. Chest 1993;104:1455-60.
98. Gonçalves RC, Buschpigell CA, Lopes AA. Circulating blood volumes in pulmonary hypertension associated with erythrocytosis - the effects of therapeutic hemodilution. Cardiol Young 2003;13:544-50.
99. Mesquita SM, Castro CR, Ikari NM, et al. Likelihood of left main coronary artery compression based on pulmonary trunk diameter in patients with pulmonary hypertension. Am J Med 2004;116:369-74.
100. Amaral HB, Zielinsky P, da Silveira AF, et al. Morphological basis for the study of the interatrial septum in the human fetus. Arq Bras Cardiol 2007;88:559-64.
101. Zielinsky P, Sallum M, Satler F, et al. Mobility of the septum primum does not depend on the foramen ovale diameter in normal fetuses. Arq Bras Cardiol 2004;83:300-3; 304-7.
102. Firpo C, Zielinsky P. Behavior of septum primum mobility in third-trimester fetuses with myocardial hypertrophy. Ultrasound Obstet Gynecol 2003;21:445-50.
103. Firpo C, Zielinsky P. Mobility of the flap valve of the primary atrial septum in the developing human fetus. Cardiol Young 1998;8:67-70.
104. Zielinsky P, Satler F, Luchese S, et al. Study of global left atrial shortening in fetuses of diabetic mothers. Arq Bras Cardiol 2004;83:470-2; 473-54.
105. Zielinsky P, Marcantonio S, Nicoloso LH, et al. Ductus venosus flow and myocardial hypertrophy in fetuses of diabetic mothers. Arq Bras Cardiol 2004;83:51-6.
106. Zielinsky P, da Costa MH, Oliveira LT, et al. Natural history of myocardial hypertrophy and its association with hyperinsulinism in infants of diabetic mothers. Arq Bras Cardiol 1997;69:389-94.
107. Zielinsky P, Piccoli AL Jr, Teixeira L, et al. Pulmonary vein pulsatility in fetuses of diabetic mothers: prenatal Doppler echocardiographic study. Arq Bras Cardiol 2003;81:604-7.
108. Menezes HS, Barra M, Belló AR, et al. Fetal myocardial hypertrophy in an experimental model of gestational diabetes. Cardiol Young 2001;11:609-13.
109. Hagemann LL, Zielinsky P. Prenatal study of hypertrophic cardiomyopathy and its association with insulin levels in fetuses of diabetic mothers. Arq Bras Cardiol 1996;66:193-8.
110. Zielinsky P, Nicoloso LH, Firpo C, et al. Alternative parameters for echocardiographic assessment of fetal diastolic function. Braz J Med Biol Res 2004;37:31-6.
111. Zielinsky P, Piccoli A Jr, Gus E, et al. Dynamics of the pulmonary venous flow in the fetus and its association with vascular diameter. Circulation 2003;108:2377-80.
112. Zimmer LP, Dillenburg RF, Dornelles AP, et al. Prenatal restriction of the foramen ovale. Arq Bras Cardiol 1997;68:285-8
113. Zielinsky P, Dillenburg RF, de Lima GG, et al. Fetal supraventricular tachyarrhythmias. Experience of a fetal cardiology referral center. Arq Bras Cardiol 1998;70:337-40.
114. Azeka E, Auler JO Jr, Marcial MB, et al. Heart transplantation in children: clinical outcome during the early postoperative period. Pediatr Transplant 2005;9:491-7.
115. Azeka E, Marcial MB, Jatene M, et al. Eight-year experience of pediatric heart transplantation: clinical outcome using non-invasive methods for the evaluation of acute rejection. Pediatr Transplant 2002;6:208-13.
116. Azeka E, Ramires JA, Ebaid M, et al. Clinical outcome after starting carvedilol in infants and children with severe dilated cardiomyopathy candidates for heart transplantation. J Heart Lung Transplant 2001;20:222.
117. Azeka E, Franchini Ramires JA, Valler C, et al. Delisting of infants and children from the heart transplantation waiting list after carvedilol treatment. J Am Coll Cardiol 2002;40:2034-8.
118. Assad RS, Cardarelli M, Abduch MC, et al. Reversible pulmonary trunk banding with a balloon catheter: assessment of rapid pulmonary ventricular hypertrophy. J Thorac Cardiovasc Surg 2000;120:66-72.
119. Dias CA, Assad RS, Caneo LF, et al. Reversible pulmonary trunk banding. II. An experimental model for rapid pulmonary ventricular hypertrophy. J Thorac Cardiovasc Surg 2002;124:999-1006.
120. Abduch MC, Assad RS, Rodriguez MQ, et al. Reversible pulmonary trunk banding III: assessment of myocardial adaptive mechanisms-contribution of cell proliferation. J Thorac Cardiovasc Surg 2007;133:1510-6.
121. Assad RS, Aiello VD, Jatene MB, et al. Cryosurgical ablation of fetal atrioventricular node: new model to treat fetal malignant tachyarrhythmias. Ann Thorac Surg 1995;60:S629-32.
122. Assad RS, Jatene MB, Moreira LF, et al. Fetal heart block: a new experimental model to assess fetal pacing. Pacing Clin Electrophysiol 1994;17:1256-63
123. Assad RS, Zielinsky P, Kalil R, et al. New lead for in utero pacing for fetal congenital heart block. J Thorac Cardiovasc Surg 2003;126:300-2.